SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/15/22 Arboretum Silverleaf Income Fd LP 10-Q 6/30/22 51:2.5M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 521K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 21K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K 11: R1 Cover HTML 64K 12: R2 Balance Sheets HTML 67K 13: R3 Balance Sheets (Parenthetical) HTML 19K 14: R4 Statements of Operations (Unaudited) HTML 66K 15: R5 Statements of Changes in Partners' Equity HTML 37K (Deficit) (Unaudited) 16: R6 Statements of Cash Flows (Unaudited) HTML 77K 17: R7 Organization and Nature of Operations HTML 30K 18: R8 Summary of Significant Accounting Policies HTML 47K 19: R9 Related Party Transactions HTML 31K 20: R10 Investments in Finance Leases HTML 22K 21: R11 Collateralized Loans Receivable HTML 23K 22: R12 Other Assets HTML 21K 23: R13 Loan Payable HTML 34K 24: R14 Fair Value of Financial Instruments HTML 33K 25: R15 Indemnifications HTML 19K 26: R16 Business Concentrations HTML 33K 27: R17 Geographic Information HTML 22K 28: R18 Commitments and Contingencies HTML 19K 29: R19 Covid-19 HTML 18K 30: R20 Subsequent Events HTML 18K 31: R21 Summary of Significant Accounting Policies HTML 77K (Policies) 32: R22 Investments in Finance Leases (Tables) HTML 21K 33: R23 Collateralized Loans Receivable (Tables) HTML 22K 34: R24 Loan Payable (Tables) HTML 19K 35: R25 Fair Value of Financial Instruments (Tables) HTML 29K 36: R26 Organization and Nature of Operations (Details HTML 41K Narrative) 37: R27 Summary of Significant Accounting Policies HTML 17K (Details Narrative) 38: R28 Related Party Transactions (Details Narrative) HTML 50K 39: R29 Schedule of Net Investments in Finance Leases HTML 24K (Details) 40: R30 Schedule of Future Principal Maturities (Details) HTML 36K 41: R31 Other Assets (Details Narrative) HTML 28K 42: R32 Schedule of Future Maturities of Loan Payable HTML 18K (Details) 43: R33 Loan Payable (Details Narrative) HTML 39K 44: R34 Schedule of Fair Values of Financial Instruments HTML 29K (Details) 45: R35 Business Concentrations (Details Narrative) HTML 42K 46: R36 Commitments and Contingencies (Details Narrative) HTML 16K 49: XML IDEA XML File -- Filing Summary XML 83K 47: XML XBRL Instance -- form10-q_htm XML 489K 48: EXCEL IDEA Workbook of Financial Reports XLSX 64K 7: EX-101.CAL XBRL Calculations -- alif-20220630_cal XML 102K 8: EX-101.DEF XBRL Definitions -- alif-20220630_def XML 178K 9: EX-101.LAB XBRL Labels -- alif-20220630_lab XML 528K 10: EX-101.PRE XBRL Presentations -- alif-20220630_pre XML 360K 6: EX-101.SCH XBRL Schema -- alif-20220630 XSD 88K 50: JSON XBRL Instance as JSON Data -- MetaLinks 193± 271K 51: ZIP XBRL Zipped Folder -- 0001493152-22-022697-xbrl Zip 130K
EXHIBIT 31.1
CERTIFICATION
I, Michael Miroshnikov, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of Arboretum Silverleaf Income Fund, L.P.; |
2. | Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant , including its subsidiaries is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: August 15, 2022 | |
/s/ Michael Miroshnikov | |
Michael Miroshnikov | |
President | |
(Principal Executive Officer) |
C:
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/15/22 | None on these Dates | ||
For Period end: | 6/30/22 | |||
List all Filings |